Sharing ideas that do good

Aussies working toward vaccines without needles

Australian company Vaxxas, is developing the world-first vaccine patch.

The company is heading toward large-scale clinical trials of its needle-free vaccine delivery platform, which could be approved for commercial use within three to five years.

The patch used by Vaxxas has a surface of thousands of micro-projections – a quarter of a millimetre long and dry-coated in vaccine. The technology deposits vaccine when applied to the skin for several seconds. These deposit within the dense population of key immune cells in the skin, developing an efficient and effective immune response. |

What do you think?

You must be logged in to post a comment.
Generic placeholder image

By Mel Raassina

14 September 2020

4 Like

Related Posts



Wireless - Brain Computer Interface
16 April 2021 by Jenny Morawsk... 0 Comments
3 Like



QLD company receives accreditation for 15-minute COVID-19 rapid test in Europe
16 April 2021 by Mel Raassina 0 Comments
1 Like



New drug for treating melanoma and other cancers
9 April 2021 by Mel Raassina 0 Comments
6 Like